Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 502 Issue 7471, 17 October 2013

Every research funding agency wants to support science that makes a difference, but there is no simple formula for identifying truly important research. And as funding gets squeezed, scientists face ever-stiffer competition for resources and jobs, and it becomes even more important to identify the best work. In a series of features and opinion pieces in this issue we examine how the impact of research is measured � and ask whether todays evaluation systems promote the most influential science. Cover by Lorenzo Petrantoni.

Editorial

  • In deciding how to judge the impact of research, evaluators must take into account the effects of emphasizing particular measures — and be open about their methods.

    Editorial

    Advertisement

  • Care must be taken not to raise unrealistic expectations for RTS,S malaria vaccine.

    Editorial
  • A look into the past frames our attempts to find extraterrestrial intelligence.

    Editorial
Top of page ⤴

World View

  • Public policy is too often derailed by assessments based on faulty data, says Martin Rees, as he calls for the formation of an international data watchdog.

    • Martin Rees
    World View
Top of page ⤴

Research Highlights

Top of page ⤴

Seven Days

  • The week in science: Nobel Peace Prize goes to chemical-weapons watchdog, Russia replaces space chief, and Italy ends controversial stem-cell trial.

    Seven Days
Top of page ⤴

News

Top of page ⤴

Correction

Top of page ⤴

News Feature

  • Many governments are assessing the quality of university research, much to the dismay of some researchers.

    • Brian Owens
    News Feature
  • Publishing in the most prestigious journals can open doors, but their cachet is under attack.

    • Eugenie Samuel Reich
    News Feature
Top of page ⤴

Comment

  • Make bibliographic citation data freely available and substantial benefits will flow, says David Shotton, director of the Open Citations Corpus.

    • David Shotton
    Comment
  • The reference is not dead — it is exploding to encompass the full spectrum of research outputs from lines of code to video frames, explains Mark Hahnel.

    • Mark Hahnel
    Comment
Top of page ⤴

Books & Arts

Top of page ⤴

Correspondence

Top of page ⤴

Obituary

Top of page ⤴

News & Views Forum

  • Analysis of cancer genomes is moving beyond the confines of a particular disease — researchers are now comparing the genetic and epigenetic characteristics of multiple tumour types. Two scientists comment on what such studies can teach us about cancer biology and how they may guide clinical practice. See Article p.333

    • Alan Ashworth
    • Thomas J. Hudson
    News & Views Forum
Top of page ⤴

News & Views

  • Lasers known as frequency combs have been used to generate molecular spectra from samples within microseconds and with high spatial resolution. This offers fresh prospects for making microscopy observations in real time. See Letter p.355

    • Yaron Silberberg
    News & Views
  • Cellular reprogramming to a stem-cell state has now been achieved in tissues of genetically engineered mice. This work signals a future for regenerative medicine in which tissue fates might be manipulated in living organisms. See Article p.340

    • Alejandro De Los Angeles
    • George Q. Daley
    News & Views
  • New observations suggest that certain extremely bright supernovae are not the nuclear explosions of very massive stars. Instead, they may be ordinary-mass events lit up by a potent central fountain of magnetic energy. See Letter p.346

    • Daniel Kasen
    News & Views
  • Lysosomes are the main degradative compartment in cells, but they are also involved in cell-death pathways. Studies using existing drugs show that lysosomes are excellent pharmacological targets for selectively destroying cancer cells.

    • Paul Saftig
    • Konrad Sandhoff
    News & Views
  • Finding a way to control how particles bind to cells could open up opportunities for biomedical research. The discovery of a method for directing the orientation of particle–cell interactions is therefore a cause for excitement.

    • Andrea J. O'Connor
    • Frank Caruso
    News & Views
  • A drug already used to treat Parkinson's disease induces repair of the damage that occurs to the myelin sheath around nerve fibres during multiple sclerosis. The finding offers new therapeutic avenues for this disease. See Article p.327

    • Hartmut Wekerle
    • Edgar Meinl
    News & Views
Top of page ⤴

Perspective

  • A checklist of criteria to determine the readiness of high-throughput ‘omics’-based tests for guiding patient therapy in clinical trials is discussed; the checklist, developed by the US National Cancer Institute in collaboration with additional scientists with relevant expertise, provides a framework to evaluate the strength of evidence for a test and outlines practical issues to consider before using the test in a clinical setting, with an aim to avoid premature advancement of omics-based tests in clinical trials.

    • Lisa M. McShane
    • Margaret M. Cavenagh
    • Barbara A. Conley
    Perspective Open Access
Top of page ⤴

Article

  • In Earth’s mantle, the shape change of olivine grains depending on temperature and the presence of melt can result in the development of olivine crystallographic preferred orientation during diffusion creep, meaning that the process may be the principal mechanism of mantle flow.

    • Tomonori Miyazaki
    • Kenta Sueyoshi
    • Takehiko Hiraga
    Article
  • Multiple sclerosis is associated with a deficiency in generation of mature oligodendroctyes; an image-based screen for oligodendrocyte differentiation inducers identified the compound benztropine, which enhances remyelination acting through muscarinic receptors and decreases clinical severity in a multiple sclerosis model system.

    • Vishal A. Deshmukh
    • Virginie Tardif
    • Luke L. Lairson
    Article
  • As part of The Cancer Genome Atlas Pan-Cancer effort, data analysis for point mutations and small indels from 3,281 tumours and 12 tumour types is presented; among the findings are 127 significantly mutated genes from cellular processes with both established and emerging links in cancer, and an indication that the number of driver mutations required for oncogenesis is relatively small.

    • Cyriac Kandoth
    • Michael D. McLellan
    • Li Ding
    Article Open Access
Top of page ⤴

Letter

  • A new multiplex technique of coherent anti-Stokes Raman spectro-imaging with two laser frequency combs is shown to record molecular spectra of broad bandwidth on a microsecond scale.

    • Takuro Ideguchi
    • Simon Holzner
    • Theodor W. Hänsch
    Letter
  • Cambrian great appendage arthropods had heads that bore a claw-like appendage pair; neuroanatomical and phylogenetic analysis of a well-preserved Alalcomenaeus fossil reveals the relationship of great appendage arthropods to Chelicerata.

    • Gengo Tanaka
    • Xianguang Hou
    • Nicholas J. Strausfeld
    Letter
  • Exploration of the interacting effect of statin exposure and genetic variation on gene expression identifies a cis-eQTL that is differentially associated with expression of the GATM gene, which encodes a rate-limiting enzyme involved in creatine synthesis, and that is associated with incidence of statin-induced myopathy, the major adverse effect of statin treatment.

    • Lara M. Mangravite
    • Barbara E. Engelhardt
    • Ronald M. Krauss
    Letter
  • Interstrand crosslink (ICL) repair involves proteins whose mutation results in the disorder Fanconi anaemia: here gene knockdown studies in mice show that the absence of HELQ, a protein previously implicated in ICL repair, compromises germ cell development and results in tumour predisposition due to defective recombination at damaged replication forks.

    • Carrie A. Adelman
    • Rafal L. Lolo
    • Simon J. Boulton
    Letter
  • A novel high-throughput sequencing kinetics approach is used to measure functional binding of the apparently nonspecific RNA-binding protein C5 to all possible sequence variants in its substrate binding site; C5 binds different substrate variants with affinities varying widely, and with a similar affinity distribution to that of highly specific nucleic-acid-binding proteins, but it does not bind its physiological RNA targets with the highest affinity.

    • Ulf-Peter Guenther
    • Lindsay E. Yandek
    • Eckhard Jankowsky
    Letter
  • This paper demonstrates that the mechanism of break-induced replication (BIR) is significantly different from S-phase replication, as it proceeds via a migrating bubble driven by Pif1 helicase, results in conservative inheritance of newly synthesized DNA, and is inherently mutagenic.

    • Natalie Saini
    • Sreejith Ramakrishnan
    • Anna Malkova
    Letter
Top of page ⤴

Feature

  • Grant reviewers are increasingly focusing on the scientific and social impact of proposed research projects.

    • Amber Dance
    Feature
Top of page ⤴

Column

  • Even if one PhD experience turns sour, another could offer the right opportunity, says Susie Crowe.

    • Susie Crowe
    Column
Top of page ⤴

Career Brief

  • Citation rates are higher when data are publicly shared, study finds.

    Career Brief
  • Canadian survey respondents complain of low pay, meagre benefits and lack of careers training.

    Career Brief
  • UK academics say research-evaluating system detracts from their work.

    Career Brief
Top of page ⤴

Futures

Top of page ⤴

Outlook

  • Knowing the structures of G-protein-coupled receptors, says Lindau keynote speaker Brian Kobilka, should help with drug development. But how is this progressing?

    • Monica Hoyos Flight
    Outlook
  • The winner of the 2007 Nobel Prize in Chemistry Gerhard Ertl ponders biology's big questions with Diane Wu.

    Outlook
  • Dan Shechtman, the winner of the 2011 Nobel Prize in Chemistry, speaks to Valerie Gerard about creating leaders and achieving prosperity though technological entrepreneurship.

    Outlook
  • Rebecca Melen talks to Robert Grubbs, the joint winner of the 2005 Nobel Prize in Chemistry, about how his research is being applied to many different processes.

    Outlook
  • Richard R. Ernst pioneered one- and two-dimensional nuclear magnetic resonance (NMR), and talks to Stephanie Harris about why dimensions are important in life as well as in science.

    Outlook
  • Richard Schrock, a recipient of the 2005 chemistry prize, speaks with Jonathan Moerdyk about whether olefin metathesis, the field he helped to pioneer, has peaked.

    Outlook
  • Are biofuels the way forward, or should we be looking to advanced solar technologies to power the future? The debate began on Lindau and continues here.

    Outlook
Top of page ⤴

Nature Outlook

  • From green chemistry to rare earth metal catalysts, the Nature Outlook: Chemistry Masterclassuses the 2013 Lindau Nobel Laureates Meeting as a basis to explore some of the most pressing issues in chemistry, presenting the perspectives of Nobel laureates as well as the young researchers aiming to emulate their success.

    Nature Outlook
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links